Stakeholders’ Perspectives on the Financial Sustainability of the HIV Response in Nigeria: A Qualitative Study
Global Health: Science and Practice · 2023
DOI: 10.9745/ghsp-d-22-00430 ↗Kurz gefasst
Qualitative Studie in der Zeitschrift Global Health: Science and Practice, 2023. Verfasst von Daniel Ogbuabor und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Health Administration and Management, Faculty of Health Sciences and Technology, University of Nigeria, Enugu Campus, Enugu, Nigeria. Hauptthemen laut MEDLINE: HIV Infections. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 59 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
BACKGROUND: Countries in sub-Saharan Africa, including Nigeria, continue to depend on donor funding to achieve their national HIV response goals. The Government of Nigeria has made limited progress in translating political commitment to reduce donor dependency into increased domestic investment to ensure the sustainable impact of the HIV response. We explored the context-specific factors affecting the financial sustainability of the HIV response in Nigeria. METHODS: Between November 2021 and March 2022, we conducted document reviews (n=13) and semistructured interviews with purposively selected national and subnational stakeholders (n=35). Data were analyzed thematically using the framework of health financing functions comprising revenue generation, pooling, and purchasing. RESULTS: Stakeholders reported that there is a low level of government funding for the HIV response, which has been compounded by the weak engagement of Ministry of Finance officials and the unpredictable and untimely release of budgeted funds. Opportunities for domestic funding include philanthropy and an HIV Trust Fund led by the private sector. Integration of HIV treatment services into social health insurance schemes has been slow. Commodity purchasing has been inefficient due to ineffective coordination. Government stakeholders have been reluctant to support one-stop-shop facilities that target key and priority populations. CONCLUSION: Opportunities exist in the government and private sectors for improving domestic health financing to support transitioning from donor support and ensuring the financial sustainability of the HIV response in Nigeria. To ensure that domestic financing for the HIV response is stable and predictable, the amount of domestic funding needs to increase and a framework that incorporates donor transition milestones must be developed, implemented, and monitored.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Health Administration and Management, Faculty of Health Sciences and Technology, University of Nigeria, Enugu Campus, Enugu, Nigeria.
- Joint United Nations Programme on HIV/AIDS, Abuja, Nigeria.
- Equitable Financing Practice, Joint United Nations Programme on HIV/AIDS, Geneva, Switzerland.
- National Agency for the Control of AIDS, Abuja, Nigeria.
- National AIDS, Sexually Transmitted Infections, and Hepatitis Control Programme, Federal Ministry of Health, Abuja, Nigeria.
Zitieren
APA
Ogbuabor, D., Olwande, C., Semini, I., Onwujekwe, O., Olaifa, Y., & Ukanwa, C. (2023). Stakeholders’ Perspectives on the Financial Sustainability of the HIV Response in Nigeria: A Qualitative Study. Global Health: Science and Practice. https://doi.org/10.9745/ghsp-d-22-00430
Vancouver
Ogbuabor D, Olwande C, Semini I, Onwujekwe O, Olaifa Y, Ukanwa C. Stakeholders’ Perspectives on the Financial Sustainability of the HIV Response in Nigeria: A Qualitative Study. Global Health: Science and Practice. 2023. doi:10.9745/ghsp-d-22-00430
BibTeX
@article{Ogbuabor2023,
author = {Ogbuabor, Daniel and Olwande, Caroline and Semini, Iris and Onwujekwe, Obinna and Olaifa, Yewande and Ukanwa, Chioma},
title = {Stakeholders’ Perspectives on the Financial Sustainability of the HIV Response in Nigeria: A Qualitative Study},
journal = {Global Health: Science and Practice},
year = {2023},
doi = {10.9745/ghsp-d-22-00430}
}
EUVIMED